Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Sell
36
LEA Quote, Financials, Valuation and Earnings
Last price:
$94.10
Seasonality move
:
1.08%
Day range:
$92.43 - $94.34
52-week range:
$73.85 - $130.69
Dividend yield:
3.27%
P/E ratio:
11.03x
P/S ratio:
0.23x
P/B ratio:
1.08x
Volume:
481.5K
Avg. volume:
655.8K
1-year change:
-27.99%
Market cap:
$5B
Revenue:
$23.3B
EPS (TTM):
$8.53
Analysts' Opinion
-
Consensus RatingLear has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $102.23, Lear has an estimated upside of 8.64% from its current price of $94.10.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $87.00 representing 7.55% downside risk from its current price of $94.10.
Fair Value
-
According to the consensus of 13 analysts, Lear has 8.64% upside to fair value with a price target of $102.23 per share.
LEA vs. S&P 500
-
Over the past 5 trading days, Lear has underperformed the S&P 500 by -1.96% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Lear does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lear revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Lear reported revenues of $5.6B.
Earnings Growth
-
Lear earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Lear reported earnings per share of $1.49.
Enterprise value:
7.2B
EV / Invested capital:
0.95x
Price / LTM sales:
0.23x
EV / EBIT:
8.78x
EV / Revenue:
0.31x
PEG ratio (5yr expected):
23.57x
EV / Free cash flow:
15.02x
Price / Operating cash flow:
10.96x
Enterprise value / EBITDA:
5.02x
Gross Profit (TTM):
$1.6B
Return On Assets:
3.27%
Net Income Margin (TTM):
2.09%
Return On Equity:
9.86%
Return On Invested Capital:
6.27%
Operating Margin:
3.27%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $21.5B | $23.6B | $22.9B | $6B | $5.6B | |
| Gross Profit | $1.5B | $1.7B | $1.6B | $398.1M | $359.2M | |
| Operating Income | $763.1M | $892.4M | $872.8M | $196.5M | $181.6M | |
| EBITDA | $1.3B | $1.5B | $1.4B | $338.3M | $308.9M | |
| Diluted EPS | $7.06 | $9.17 | $8.53 | $1.90 | $1.49 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7B | $6.9B | $7.6B | $7.9B | $7.7B | |
| Total Assets | $13.4B | $13.7B | $14.4B | $14.9B | $14.6B | |
| Current Liabilities | $5.2B | $5.1B | $5.6B | $5.9B | $5.8B | |
| Total Liabilities | $8.7B | $8.9B | $9.4B | $9.9B | $9.8B | |
| Total Equity | $4.7B | $4.8B | $5B | $5B | $4.8B | |
| Total Debt | $2.3B | $2.6B | $2.6B | $2.8B | $2.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $765.1M | $1.3B | $1B | -$34.6M | -$127.7M | |
| Cash From Investing | -$637.2M | -$762.9M | -$499.1M | -$110.9M | -$67M | |
| Cash From Financing | -$398.6M | -$440.9M | -$674M | -$103.9M | -$84M | |
| Free Cash Flow | $145.4M | $622M | $477.9M | -$148.2M | -$231.7M | |
LEA
Sector
Market Cap
$5B
$414M
Price % of 52-Week High
72%
71.46%
Dividend Yield
3.27%
0%
Shareholder Yield
11.95%
3.95%
1-Year Price Total Return
-27.99%
-14.1%
Beta (5-Year)
1.305
0.786
Dividend yield:
3.27%
Annualized payout:
$3.08
Payout ratio:
35.9%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$93.37
200-day SMA
Sell
Level
$98.45
Bollinger Bands (100)
Buy
Level
85.44 - 97.48
Chaikin Money Flow
Sell
Level
-4.1M
20-day SMA
Buy
Level
$88.49
Relative Strength Index (RSI14)
Buy
Level
62.49
ADX Line
Buy
Level
28.92
Williams %R
Neutral
Level
-25.2
50-day SMA
Buy
Level
$88.08
MACD (12, 26)
Buy
Level
2.51
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
97.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.9223)
Sell
CA Score
(Annual)
Level (-0.3616)
Buy
Beneish M-Score
(Annual)
Level (-2.6596)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (0.2272)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns most of its revenue from the seating segment.
Stock Forecast FAQ
In the current month, LEA has received 3 Buy ratings 10 Hold ratings, and 0 Sell ratings. The LEA average analyst price target in the past 3 months is $102.23.
-
Where Will Lear Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lear share price will rise to $102.23 per share over the next 12 months.
-
What Do Analysts Say About Lear?
Analysts are divided on their view about Lear share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lear is a Sell and believe this share price will drop from its current level to $87.00.
-
What Is Lear's Price Target?
The price target for Lear over the next 1-year time period is forecast to be $102.23 according to 13 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is LEA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lear is a Hold. 10 of 13 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of LEA?
You can purchase shares of Lear via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lear shares.
-
What Is The Lear Share Price Today?
Lear was last trading at $94.10 per share. This represents the most recent stock quote for Lear. Yesterday, Lear closed at $94.10 per share.
-
How To Buy Lear Stock Online?
In order to purchase Lear stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is up 3.21% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 0.85% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is down 10.31% over the past day.
